These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9063480)
81. Vincristine infusion in refractory gynecologic malignancies. Jackson DV; Jobson VW; Homesley HD; Welander C; Hire EA; Pavy MD; Votaw ML; Richards F; Muss HB Gynecol Oncol; 1986 Oct; 25(2):212-6. PubMed ID: 3758831 [TBL] [Abstract][Full Text] [Related]
82. Hematologic monitoring in patients with cancer. A study of the Gynecologic Oncology Group. Curry SL; Muss HB; Blessing JA; Arseneau J Am J Clin Oncol; 1987 Apr; 10(2):163-6. PubMed ID: 3565315 [TBL] [Abstract][Full Text] [Related]
83. Advances in the chemotherapy of gynecologic malignancies. Ozols RF Hematol Oncol; 1992; 10(1):43-51. PubMed ID: 1348719 [TBL] [Abstract][Full Text] [Related]
84. [Proceedings: Chemotherapy of malignant gynecologic (ovarian) neoplasms]. von Töttössy B Arch Gynakol; 1973 Sep; 214(1):389-91. PubMed ID: 4801492 [No Abstract] [Full Text] [Related]
85. The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients. Hansen J; Stephan JM; Freesmeier M; Bender D; Button A; Goodheart MJ Gynecol Oncol; 2015 Jul; 138(1):154-8. PubMed ID: 25958318 [TBL] [Abstract][Full Text] [Related]
86. [On the behavior of the leukocyte sedimentation rate during antimitotic therapy of gynecologic neoplasms]. Di Fabio C Riv Ital Ginecol; 1965; 49(4):333-43. PubMed ID: 5834396 [No Abstract] [Full Text] [Related]
93. [Findings concerning the use of bleomycin acidified cellulose gauze against gynecological cancers]. Uchida S; Murata M Gan To Kagaku Ryoho; 1989 Jan; 16(1):135-7. PubMed ID: 2463793 [No Abstract] [Full Text] [Related]
94. [Gynecologic Cancer Revisiting First-Line Chemotherapy for Advanced Ovarian Cancer]. Fujiwara K Gan To Kagaku Ryoho; 2023 Feb; 50(2):151-152. PubMed ID: 36807161 [No Abstract] [Full Text] [Related]
95. Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. Li YF; Fu S; Hu W; Liu JH; Finkel KW; Gershenson DM; Kavanagh JJ Int J Gynecol Cancer; 2007; 17(4):739-63. PubMed ID: 17309673 [TBL] [Abstract][Full Text] [Related]
96. Clinical trial of cisplatin in advanced malignancies. Qiao SM Chin Med J (Engl); 1982 Aug; 95(8):557-64. PubMed ID: 6814856 [No Abstract] [Full Text] [Related]
97. Analysis of clinical trials in gynecologic cancer--timing and interpretation. Blessing JA; Anderson B Gynecol Oncol; 1986 Mar; 23(3):275-83. PubMed ID: 3514389 [TBL] [Abstract][Full Text] [Related]
98. [1st experiences with the "cancer-serum-index" in gynecologic malignancies]. Szalay S; Tatra G; Janisch H Gynakol Rundsch; 1980 Jun; 20 Suppl 2():142-3. PubMed ID: 7194261 [No Abstract] [Full Text] [Related]
99. [Cyclophosphamide in high dosage forms as gynecologic neoplasm therapy]. Tukiainen P Duodecim; 1968; 84(12):763-73. PubMed ID: 5685562 [No Abstract] [Full Text] [Related]
100. [Hormone therapy in the follow-up care of gynecologic cancers]. Gynakol Rundsch; 1984; 24(1):63-72. PubMed ID: 6714811 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]